KIORA PHARMACEUTICALS INC KPRX
KIORA PHARMACEUTICALS INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | 28.2% | — | — | — | -68104.8% | — | -656.3% | — | — |
| Net margin | — | 22.4% | — | — | — | -67102.9% | -264.2% | -654.2% | -3243.5% | — |
| FCF margin | — | 53.4% | — | — | — | -60844.6% | -303.6% | -657.5% | -1596.4% | -1257.1% |
| Return on assets | -44.7% | 9.9% | -91.3% | -72.7% | -68.4% | -53.4% | -70.2% | -75.7% | -92.4% | — |
| Return on equity | -67.2% | 14.0% | -204.8% | -119.1% | -94.5% | -83.2% | -107.2% | -121.0% | -175.0% | — |
| Debt / equity | — | — | — | — | — | 0.03× | 0.00× | — | — | — |
| Current ratio | 5.99 | 4.94 | 2.90 | 2.35 | 5.59 | 0.97 | 3.06 | 2.19 | 0.57 | 0.57 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.